Healthcare CEOs are hiding behind industry lobbying groups instead of publicly using their power to push for changes in the Republicans' healthcare reform bill.
SSM Health is launching a financial improvement plan and Texas Health Resources is promoting a new hospital and insurance joint venture as first-quarter operating income falls at each.
Joe Moser, a key architect of Indiana's alternative Medicaid expansion program, has stepped down as the state's Medicaid director. Since his appointment in 2013, he oversaw the care of more than 1.5 million Medicaid and CHIP enrollees.
A California bill that would eliminate health insurance companies and provide government-funded health coverage for everyone in the state would cost $400 billion and require significant tax increases, legislative analysts said Monday.
More oversight of disease awareness promotions could curb wasteful diagnostic testing, overdiagnosis and inappropriate therapy, researchers said.
Community Health Systems has rejected a $2.4 billion buyout offer for its eight Fort Wayne, Ind., hospitals, saying Monday the proposal by physicians and private-equity players came in at least $1 billion lower than what it was worth.
The Trump administration is proposing a $636 billion cut in federal funding for CMS programs over the next decade.
President Donald Trump is expected to propose cutting more than $800 billion from Medicaid over 10 years. The cuts are likely to ruffle some feathers.
Catholic Health Initiatives halved its operating losses to $40.1 million in the third quarter of fiscal 2017, and looks to cut those losses even further by divesting its money-losing Louisville hospitals.
The fate of cost-sharing reductions remains undecided as the administration neither drops its appeal or presses it forward.
MetroHealth's 12- and 16-bed hospitals coming online next year will join the ranks of a series of other so-called "micro-hospitals" popping up around the country.
Chicago-based Iterum Therapeutics has raised $65 million in an oversubscribed funding round to develop an oral and intravenous antibiotic to treat drug-resistant infections that spread in hospitals.